The rat subcutaneous air sec model: A new and simple method for in vivo screening of antiangiogenesis

Pharmacology and Toxicology

Volumn 81, Issue 6, 1997, Pages 280-284

  Lichtenberg, Jens ^a,b   Hansen, Christian Abildgaard ^a   Skak Nielsen, Tine ^a   Bay, Claus ^a   Mortensen, Jens Thing ^a   Binderup, Lise ^a  

^a LEO PHARMA A S   (Denmark)

^b Leo Pharmaceutical Products ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; FUMAGILLOL CHLOROACETYLCARBAMATE;

AIR SAC; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; FEMALE; IN VIVO STUDY; MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

AIR; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CORNEA; CYCLOHEXANES; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; INJECTIONS, SUBCUTANEOUS; IODINE RADIOISOTOPES; NEOVASCULARIZATION, PATHOLOGIC; PROSTHESES AND IMPLANTS; RATS; RATS, SPRAGUE-DAWLEY; SESQUITERPENES; SURGICAL SPONGES;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0030838323     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Antoine, N., R. Greimers, C. De Roanne, M. Kusaka, E. Heinen, L.J. Simar & V. Castronovo: AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle. Cancer Res. 1994, 54, 2073-2076.
2. Bishop, J., A. K. Greenham & E. J. Lewis: A novel model for study of cartilage degradation. J. Pharmacol. Toxicol. Meth. 1993, 30, 19-25.
3. Edwards, J. C., A. D. Sedgwick & D. A. Willoughby: The formation of a structure with the features of synovial lining by subcutaneous injection of air. An in vivo tissue culture system. J. Pathol. 1981, 134, 147-156.
4. Fajardo, A. F., J. Kowalski, H. H. Kwan, S. D. Prionas & A. C. Allison: The disk angiogenesis system. Lab. Invest:. 1988, 58, 718-724.
5. Fidler, I. & L. M. Ellis: The implications of angiogenesis for biology and therapy of cancer metastasis. Cell 1994, 79, 185-188.
6. Folkman, J.: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1995, 1, 27-31.
7. Gimbrone, M. A., R. S. Cotran, S. B. Leapman & J. Folkman: Tumour growth and neo- vascularization: An experimental model using the rabbit cornea. J. Nat. Cancer Inst. 1974, 52, 413-427.
8. Hobson, B.: Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Brit. J. Cancer 1994, 49, 405-413.
9. Knighton, D. R. & V. D. Fiegel: Regulation of cutaneous wound healing by growth factors and the microenvironment. Invest. Radiol. 1991, 26, 604-611.
10. Kowanko, I. C., T. P. Gordon, A. M. Rozenbilds, P. M. Brooks & P. J. Roberts-Thomson: The subcutaneous air pouch model of synovium and the inflammatory response to heat aggregated gammaglobulin. Agents and Actions 1986, 18, 421-428.
11. Kusaka, M., K. Sudo, T. Fujita, S. Marui, F. Itoh, D. Ingber & J. Folkman: Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem. Biophys. Res. Commun. 1991, 174, 1070-1076.
12. Passaniti, A., R. M. Taylor, R. Pili, Y. Guo, P. V. Long, J. A. Haney, R. R. Pauly, D. S. Grant & G. R. Martin: A simple quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 1992, 67, 519-528.
13. Schreiber, A. B., M. E. Winkler & R. Derynck: Transforming growth factor-α: A more potent angiogenic mediator than epidermal growth factor. Science 1986, 232, 1250-1253.
14. Shaker, A. M.: Angiogenesis promoters and inhibitors: potential therapeutic implications. International Business Communications: therapeutic implications of angiogenesis inhibitors and stimulators. Elsevier Science Ltd. 1996, 1357-4310.
15. Tanaka, T.: Prevention of metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Cancer Res. 1995, 55, 836-839.